Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
Condition: HER2-positive Breast Cancer Intervention: Drug: [18F]FMISO PET/MRI imaging Sponsor: University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials